142
Active Trials
8,450+
Patients Enrolled
38
Countries
94.2%
Protocol Adherence
🛡️

Ethics & Governance

All trials undergo rigorous Institutional Review Board (IRB) / Independent Ethics Committee (IEC) review. We strictly adhere to ICH-GCP guidelines and the Declaration of Helsinki.

📊

Data Transparency

Clinical study reports, protocols, and aggregate results are published in full. Individual patient data is de-identified and stored under SOC 2 Type II and HIPAA-compliant infrastructure.

🌍

Global Regulatory Alignment

Operational compliance with FDA (21 CFR Parts 50, 54, 56, 312), EMA, PMDA, and MHRA standards. Real-world evidence integration for post-market surveillance.

🤝

Patient-Centric Design

Decentralized trial options, travel compensation, 24/7 clinical support lines, and dynamic consent frameworks ensure participant safety and informed engagement.